As we approach the 10th anniversary of the sequencing of the first human genome, the price of sequencing has gone down from a few million dollars to a few thousand. Researchers are talking about the advent of $1,000 genome as sequencing technology becomes faster and more efficient. But does cheaper mean better? Not necessarily, says The New Scientist's Michael Le Page.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.